Mednet Reports
PRIORITY PRESS - The Canadian Immunization Conference (CIC)
Overcoming Low Influenza Vaccine Effectiveness
Ottawa, Ontario / December 4-6, 2018
Ottawa - Increasing the effectiveness of influenza vaccines is one of the core strategies for dealing with future seasonal influenza outbreaks and pandemics. While egg-based manufacturing processes for influenza vaccines have been in place...
MEDICAL FRONTIERS - Annual Meeting of the American Society of Hematology
A New Era of Chemotherapy-free Treatments Emerges for Chronic Lymphocytic Leukemia
Atlanta, Georgia / December 9-12, 2017
Atlanta - The recent approvals of many effective, well-tolerated novel agents for chronic lymphocytic leukemia (CLL) have changed the treatment landscape. Researchers are learning how best to sequence and potentially combine novel...
MEDICAL FRONTIERS - Annual Meeting of the American College of Rheumatology
Update on the Impact of IL-17A Inhibition on Disease Severity and Structural Changes in Axial Spondyloarthritis
San Diego, California / November 4-7, 2017
San Diego - Joint symptoms and structural joint damage are two targets of the treatment of axial spondyloarthritis (axSpA), which encompasses psoriatic arthritis and ankylosing spondylitis. Inhibition of interleukin-17A, a key cytokine...
MEDICAL FRONTIERS - 26th European Academy of Dermatology and Venereology Congress
A Long-Term Update with IL-17A Inhibition
Geneva, Switzerland / September 13-17, 2017
Geneva - Long-term data are emerging with the interleukin (IL)-17A inhibitors in the treatment of patients with moderate to severe plaque psoriasis and psoriatic arthritis. These findings, from open-label extensions of phase 2 and phase 3...
MEDICAL FRONTIERS - 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
A New Era Emerges In Melanoma Control, Including Brain Metastases
Chicago, Illinois / June 2-6, 2017
Chicago - A growing proportion of patients with advanced metastatic melanoma are surviving for long periods due largely to two approaches. One involves combining therapies targeted at the BRAF and MEK pathways. The other involves...
PRIORITY PRESS - 15th Conference of the International Society of Travel Medicine
Understanding Japanese Encephalitis in the Context of Travel Medicine
Barcelona, Spain / May 14-18, 2017
Barcelona - Japanese encephalitis is caused by a mosquito-borne flavivirus, predominant in Asian countries, belonging in the same genus as the dengue, yellow fever, West Nile and Zika viruses.1,2 Even though the incidence is very low, and...
PRIORITY PRESS - The Canadian Immunization Conference (CIC)
Short-term Thinking about Influenza Underestimates the True Disease Burden in Older Patients
Ottawa, Ontario / December 6-8, 2016
Ottawa - Short-term thinking about influenza infection limits the illness to the acute period of illness when in fact, functional decline following hospitalization for influenza can be persistent and life-altering. Among the well, vaccine...
PRIORITY PRESS - 25th Congress of European Academy of Dermatology and Venerology (EADV)
Comorbidities in Psoriasis in the Dermatology Clinic: New Considerations
Vienna, Austria / September 28- October 2, 2016
Vienna - Over the past decade there has been growing recognition that psoriasis is more than just an isolated skin disease as it is has become associated with other disorders. A common trend featured throughout the conference was the...
PRIORITY PRESS - 28th International Congress of Pediatrics (IPA 2016)
Primary Care Primer on Seasonal Influenza Vaccination and Why it Matters in Children
Vancouver, BC / August 17-22, 2016
Vancouver - Uptake of the seasonal influenza vaccine is far from optimal in pediatric practice and physicians have an important role to play in helping parents understand why influenza vaccination is critical for infants and young children....
MEDICAL OPTIONS - Respirology
Evolution in Management of Pulmonary Arterial Hypertension (PAH)
March 2016
Targeting of the Prostacyclin Pathway in PAH Editorial ReviewWritten by: Theodore Bosworth Steeve Provencher, MD, MPH, FRCPCDirector, Pulmonary Hypertension ProgramProfessor, Université LavalQuebec City, Quebec For the treatment...
